Thrombosis
News
Factor VIII product approved for hemophilia A
The US Food and Drug Administration (FDA) has approved Jivi® (antihemophilic factor [recombinant] PEGylated-aucl) for the treatment of hemophilia...
News
A new standard of care in hemophilia A?
Results of a phase 3 trial showed that prophylaxis with emicizumab significantly reduced bleeds, compared to no prophylaxis, in patients with...
From the Journals
Rivaroxaban superior to aspirin for extended VTE treatment
Researchers said there is no longer a place for aspirin in extended VTE treatment.
News
Rivaroxaban doesn’t reduce risk of fatal VTE
MUNICH—Extended thromboprophylaxis with rivaroxaban does not significantly reduce the risk of fatal venous thromboembolism (VTE) in patients...
Conference Coverage
VTE risk unchanged by rivaroxaban after discharge
The MARINER study looked at postdischarge rivaroxaban in individuals who had been recently hospitalized and were at an increased risk of venous...
News
D-dimer and WCP can render VDUs unnecessary
Venous duplex ultrasounds (VDUs) may be over-utilized in patients suspected of having deep vein thrombosis (DVT), according to research published...
News
FDA grants priority review to drug for PNH
The US Food and Drug Administration (FDA) has accepted for priority review the biologics license application (BLA) for ALXN1210, a long-acting C5...
News
Marzeptacog alfa may prevent bleeds in hemophilia A/B with inhibitors
BOSTON—The activated factor VIIa variant marzeptacog alfa has demonstrated efficacy as prophylaxis for patients with hemophilia A or B who also...
Conference Coverage
A new, simple, inexpensive DVT diagnostic aid
NEW ORLEANS – The CBC holds info that outperforms the D-dimer test.
News
Some PE patients don’t require hospitalization
A new study suggests that certain patients with acute pulmonary embolism (PE) may be better off receiving outpatient treatment. Researchers...
News
Real-world bleeding risk with ibrutinib
The Bruton tyrosine kinase inhibitor ibrutinib has been linked to a 20-fold increased risk of major bleeding in blood cancer patients taking...